Treatment of Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumors in First Line With Nilotinib
Clinical trial NCT00756509 · COMPLETED
Trial details
- NCT number
- NCT00756509
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2008-08-29
- Primary completion
- 2024-12-18
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.